P3 Health Partners Inc. (PIII)

NEUTRAL

HealthcareMedical Care FacilitiesUnited States

Fundamental

Precio

$10.07

Capitalización Bursátil

$2.04B

Yahoo Finance TradingView Noticias Sitio web

Parte 1 · Cuánto vale la empresa

Resumen

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Balance y Liquidez

Ingresos

$1.50B

Últimos 12 meses (hasta 30/6/2026)

Beneficio Neto

$-98M

Últimos 12 meses (hasta 30/6/2026)

Flujo de Caja Libre

Patrimonio Neto Total

$-155M

Pasivo Total

$797M

Ratio de Liquidez

0.46

Cobertura de Intereses

2.44

Deuda/EBITDA

Beneficio Por Acción

Ingresos y Beneficio Neto

Flujo de Caja Libre

Desglose de Ingresos

Estado histórico

Márgenes en el tiempo

La deuda en el tiempo

Cuánto pesa la deuda

Cuadro de crecimiento

Crecimiento — Ingresos

Estimación de Valor Justo

General caseInfravalorado

Valor Justo

$18.00

Precio Actual

$10.07

Margen de Seguridad

+44.1%

Rango de Valor Justo

$17.10 - $18.90

Métodos de Estimación

Analyst price target:$18.00

Discounted cash flow (DCF):Not enough data to compute it

Earnings multiple (P/E):Not enough data to compute it

Graham growth formula:Not enough data to compute it

Earnings power value (EPV):Not enough data to compute it

Justified P/B:$15.59

Dividend discount (Gordon):Not enough data to compute it

P/FFO, funds from operations:Not enough data to compute it

Mid-cycle earnings:Not enough data to compute it

Revenue multiple:Not enough data to compute it

Consenso de Analistas:Compra Fuerte (6B / 2H / 0S)

Última Sorpresa de Resultados:+67.41%

Métricas de Valoración

Ratio P/E

ROE

95.3%

Ratio P/B

0.54

P/FCF

Margen Bruto

ROIC

-44.2%

Radar de Rentabilidad

Value Creation (Economic Moat)

ROIC

-44.2%

WACC

14.7%

ROIC − WACC

-58.9 pp

ROIC is below the cost of capital — the company is destroying value for every dollar invested.

Criterios de Análisis Fundamental

Superado (6)

P/B Ratio 0.54
Interest Coverage
ROE 10.3%
Revenue Growth 5Y 24.6%
Analyst Consensus 75% Buy
Net Margin Trend -6.6% vs -10.0%

Fallido (11)

EPS shows upward trend
Price CAGR -50.65%
ROIC -44.2%
Operating Margin -9.9%
Current Ratio
Return on Tangible Assets
Low reliance on intangibles
DCF valuation (Unknown)
Earnings Surprise avg -4.8%
Share Dilution 30.1%
Piotroski F-Score 2/9

No disponible (10)

Gross Margin NaN%
P/FCF NaN
Dividend Payout NaN%
Debt/Equity ratio
Positive Free Cash Flow
CapEx intensity
Debt/EBITDA
Price below Graham Number
PEG Ratio (need PE > 0 and growth > 0)
Earnings Quality (OCF/Net Income)

Piotroski F-Score

2/9

Preocupaciones financieras graves

score

criteria

Calidad de los Beneficios

Baja calidad: investigue la contabilidad

Dilución de Acciones

30.1%

Emitiendo nuevas acciones, diluyendo la participación

Gobernanza

Equipo Directivo

Nombre	Cargo	Edad
Dr. Aric Coffman M.D.	CEO, President & Director	51
Dr. Amir Bacchus M.B.A., M.D.	Co-Founder, Chief Medical Officer & Director	60
Mr. Leif Pedersen	Chief Financial Officer	49
Mr. William Bettermann	Executive VP & COO	-
Mr. Devery Goodey	Senior Vice President of Technology	-
Ms. Sarah Bussmann B.S.N., CRNI, M.H.A., R.N.	Chief Administrative Officer	-

Parte 2 · El precio y el momento de entrar

Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.

Latest News

Recent headlines for PIII, sourced from Markets Gazette.

No recent news for PIII.